nippon shinyaku co ltd annual report 2006 profile contents 1consolidated financial highlights 2 at a glance 4 message from the president 6 research and development 10 manufacturing 12 medical representative activity 13 recent developments 14 corporate governance basic policy implementation 15 environmental technology section 16 board of directors auditors 17 18 management s discussion & analysis 36 directory service network 37 investor information forward looking statements contained in this con cerning plans predictions strategies to improve future performance are based on informa tion currently available company inevitably involve cer tain element risk uncertainties actual results may therefore differ those founded ancient capital kyoto 1919 is an r&d oriented pharmaceutical specializing manufacture sale ethical drugs particularly for treatment contempo rary diseases such as cardiovascular gastrointestinal uro logical inflammatory allergic hematologic malignancies making good use its techno know how accumulated field
